subgroup of
vaccine)
→
ReceivesAction
→
approved for use
| Typicality: | 0.512 |
| Saliency: | 0.613 |
| in 2006 | 4 | temporal |
| in the united states | 4 | location |
| in males | 3 | other |
| hpv vaccine → be approved for → use | 7 |
| hpv vaccine → be approved by → the fda | 6 |
| hpv vaccine → be → approved | 6 |
| negative | neutral | positive |
| 0.131 | 0.663 | 0.206 |
| Raw frequency | 19 |
| Normalized frequency | 0.613 |
| Modifier score | 0.500 |
| Perplexity | 21.657 |